Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 313

PubMed for Gene (Select 1803)

1.
2.

Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells.

Röhrborn D, Eckel J, Sell H.

FEBS Lett. 2014 Nov 3;588(21):3870-7. doi: 10.1016/j.febslet.2014.08.029. Epub 2014 Sep 12.

PMID:
25217834
3.

Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26.

Wang Q, Qi J, Yuan Y, Xuan Y, Han P, Wan Y, Ji W, Li Y, Wu Y, Wang J, Iwamoto A, Woo PC, Yuen KY, Yan J, Lu G, Gao GF.

Cell Host Microbe. 2014 Sep 10;16(3):328-37. doi: 10.1016/j.chom.2014.08.009.

PMID:
25211075
4.

The nonglycemic actions of dipeptidyl peptidase-4 inhibitors.

Kim NH, Yu T, Lee DH.

Biomed Res Int. 2014;2014:368703. doi: 10.1155/2014/368703. Epub 2014 Jul 21. Review.

5.

Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and Metabolic Disorders Study.

Zheng T, Gao Y, Baskota A, Chen T, Ran X, Tian H.

J Clin Endocrinol Metab. 2014 Nov;99(11):E2330-4. doi: 10.1210/jc.2014-1480. Epub 2014 Jul 16.

PMID:
25029421
6.

Increased plasma DPP4 activities predict new-onset atherosclerosis in association with its proinflammatory effects in Chinese over a four year period: A prospective study.

Zheng TP, Yang F, Gao Y, Baskota A, Chen T, Tian HM, Ran XW.

Atherosclerosis. 2014 Aug;235(2):619-24. doi: 10.1016/j.atherosclerosis.2014.05.956. Epub 2014 Jun 8.

PMID:
24968315
7.

Prognostic significance of CD26 in patients with colorectal cancer.

Lam CS, Cheung AH, Wong SK, Wan TM, Ng L, Chow AK, Cheng NS, Pak RC, Li HS, Man JH, Yau TC, Lo OS, Poon JT, Pang RW, Law WL.

PLoS One. 2014 May 28;9(5):e98582. doi: 10.1371/journal.pone.0098582. eCollection 2014.

8.

CD26/DPPIV down-regulation in endometrial stromal cell migration in endometriosis.

Tan CW, Lee YH, Tan HH, Lau MS, Choolani M, Griffith L, Chan JK.

Fertil Steril. 2014 Jul;102(1):167-177.e9. doi: 10.1016/j.fertnstert.2014.04.001. Epub 2014 May 10.

PMID:
24825423
9.

In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors.

Nongonierma AB, Mooney C, Shields DC, FitzGerald RJ.

Peptides. 2014 Jul;57:43-51. doi: 10.1016/j.peptides.2014.04.018. Epub 2014 May 2.

PMID:
24793774
10.

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia.

Herrmann H, Sadovnik I, Cerny-Reiterer S, Rülicke T, Stefanzl G, Willmann M, Hoermann G, Bilban M, Blatt K, Herndlhofer S, Mayerhofer M, Streubel B, Sperr WR, Holyoake TL, Mannhalter C, Valent P.

Blood. 2014 Jun 19;123(25):3951-62. doi: 10.1182/blood-2013-10-536078. Epub 2014 Apr 28.

11.

Serum dipeptidyl peptidase-IV: a better screening test for early detection of mucopolysaccharidosis?

Kurt I, Sertoglu E, Okur I, Tapan S, Uyanık M, Kayadıbı H, Ezgu FS, Aydın HI, Hasanoglu A.

Clin Chim Acta. 2014 Apr 20;431:250-4. doi: 10.1016/j.cca.2014.02.012. Epub 2014 Feb 28.

PMID:
24582858
12.

Molecular dynamic simulations reveal the mechanism of binding between xanthine inhibitors and DPP-4.

Gu Y, Wang W, Zhu X, Dong K.

J Mol Model. 2014 Feb;20(2):2075. doi: 10.1007/s00894-014-2075-1. Epub 2014 Jan 31.

PMID:
24481594
13.

Low DPP4 expression and activity in multiple sclerosis.

Tejera-Alhambra M, Casrouge A, de Andrés C, Ramos-Medina R, Alonso B, Vega J, Albert ML, Sánchez-Ramón S.

Clin Immunol. 2014 Feb;150(2):170-83. doi: 10.1016/j.clim.2013.11.011. Epub 2013 Nov 28.

PMID:
24412911
14.

Altered peptidase activities in thyroid neoplasia and hyperplasia.

Larrinaga G, Blanco L, Errarte P, Beitia M, Sanz B, Perez I, Irazusta A, Sánchez CE, Santaolalla F, Andrés L, López JI.

Dis Markers. 2013;35(6):825-32. doi: 10.1155/2013/970736. Epub 2013 Nov 27.

15.

Variation at the DPP4 locus influences apolipoprotein B levels in South Asians and exhibits heterogeneity in Europeans related to BMI.

Bailey SD, Xie C, Paré G, Montpetit A, Mohan V, Yusuf S, Gerstein H, Engert JC, Anand SS; EpiDREAM and INTERHEART Investigators.

Diabetologia. 2014 Apr;57(4):738-45. doi: 10.1007/s00125-013-3142-3. Epub 2013 Dec 21.

PMID:
24362726
16.

The receptor binding domain of MERS-CoV: the dawn of vaccine and treatment development.

Zhou N, Zhang Y, Zhang JC, Feng L, Bao JK.

J Formos Med Assoc. 2014 Mar;113(3):143-7. doi: 10.1016/j.jfma.2013.11.006. Epub 2013 Dec 15. Review.

PMID:
24342026
17.

Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro.

Sell H, Blüher M, Klöting N, Schlich R, Willems M, Ruppe F, Knoefel WT, Dietrich A, Fielding BA, Arner P, Frayn KN, Eckel J.

Diabetes Care. 2013 Dec;36(12):4083-90. doi: 10.2337/dc13-0496. Epub 2013 Oct 15.

18.

The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus.

Ravassa S, Barba J, Coma-Canella I, Huerta A, López B, González A, Díez J.

Cardiovasc Diabetol. 2013 Oct 7;12:143. doi: 10.1186/1475-2840-12-143.

19.

Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody.

Ohnuma K, Haagmans BL, Hatano R, Raj VS, Mou H, Iwata S, Dang NH, Bosch BJ, Morimoto C.

J Virol. 2013 Dec;87(24):13892-9. doi: 10.1128/JVI.02448-13. Epub 2013 Sep 25.

20.

Identification of altered dipeptidyl-peptidase activities as potential biomarkers for unipolar depression.

Deng J, Lamb JR, McKeown AP, Miller S, Muglia P, Guest PC, Bahn S, Domenici EH, Rahmoune H.

J Affect Disord. 2013 Nov;151(2):667-72. doi: 10.1016/j.jad.2013.07.015. Epub 2013 Jul 31.

PMID:
23948634
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk